Literature DB >> 24374533

Splenectomy and the risk of sepsis: a population-based cohort study.

Gustaf Edgren1, Rikke Almqvist, Mikael Hartman, Garth H Utter.   

Abstract

OBJECTIVE: We sought to estimate the long-term risk of sepsis in patients who underwent splenectomy before, during, and after implementation of vaccination.
BACKGROUND: Because patients who have undergone splenectomy are considered at increased risk of bacterial sepsis, they typically receive vaccination, education, and occasionally antibiotic prophylaxis. However, the extent to which these interventions have actually reduced the risk of sepsis remains unclear.
METHODS: Retrospective cohort study encompassing all patients in the Swedish national inpatient register, who underwent splenectomy in 1970-2009. Patients were followed for hospitalization for or death from sepsis, as identified using national inpatient and cause of death registers. Relative risks, comparing patients to the background population were expressed as standardized incidence ratios (SIRs) and standardized mortality ratios (SMRs).
RESULTS: Altogether, 20,132 splenectomized patients were included. The overall SIR for hospitalization for sepsis was 5.7 [95% confidence interval (CI), 5.6-6.0]. However, risks depended on the indication for splenectomy, with SIRs varying from 3.4 (95% CI, 3.0-3.8) for trauma patients to 18 (95% CI, 16-19) for patients with hematologic malignancies. SMRs ranged from 3.1 (95% CI, 2.1-4.3) for trauma to 8.7 (95% CI, 6.8-11) for hematologic disease. In regression analyses adjusting for age at splenectomy, follow-up time, sex, and calendar year of splenectomy, there were no significant risk decreases after implementation of routine vaccination, except for in patients with malignant and non-malignant hematologic disease.
CONCLUSIONS: The risk of hospitalization or death from sepsis is high in patients who previously underwent splenectomy and depends on the indication for splenectomy. The effectiveness of current vaccination practices warrants further evaluation.

Entities:  

Mesh:

Year:  2014        PMID: 24374533     DOI: 10.1097/SLA.0000000000000439

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  20 in total

1.  Outcomes after splenectomy in children: a 48-year population-based study.

Authors:  Mohammad A Khasawneh; Nicolas Contreras-Peraza; Matthew C Hernandez; Christine Lohse; Donald H Jenkins; Martin D Zielinski
Journal:  Pediatr Surg Int       Date:  2019-02-02       Impact factor: 1.827

Review 2.  Human spleen microanatomy: why mice do not suffice.

Authors:  Birte S Steiniger
Journal:  Immunology       Date:  2015-07       Impact factor: 7.397

Review 3.  Practical review of immunizations in adult patients with cancer.

Authors:  Ella J Ariza-Heredia; Roy F Chemaly
Journal:  Hum Vaccin Immunother       Date:  2015-06-25       Impact factor: 3.452

4.  Vaccination coverage and mortality after splenectomy: results from an Italian single-centre study.

Authors:  Antonio Di Sabatino; Marco Vincenzo Lenti; Francesco Paolo Tinozzi; Marina Lanave; Ivana Aquino; Catherine Klersy; Piero Marone; Carlo Marena; Andrea Pietrabissa; Gino Roberto Corazza
Journal:  Intern Emerg Med       Date:  2017-08-10       Impact factor: 3.397

5.  Identification of a Novel Antisepsis Pathway: Sectm1a Enhances Macrophage Phagocytosis of Bacteria through Activating GITR.

Authors:  Xingjiang Mu; Peng Wang; Xiaohong Wang; Yutian Li; Hongyan Zhao; Qianqian Li; Kobina Essandoh; Shan Deng; Tianqing Peng; Guo-Chang Fan
Journal:  J Immunol       Date:  2020-08-07       Impact factor: 5.422

Review 6.  Tissue-Resident Macrophages in the Control of Infection and Resolution of Inflammation.

Authors:  Xingjiang Mu; Yutian Li; Guo-Chang Fan
Journal:  Shock       Date:  2021-01-01       Impact factor: 3.454

7.  Sectm1a Facilitates Protection against Inflammation-Induced Organ Damage through Promoting TRM Self-Renewal.

Authors:  Xingjiang Mu; Hongkuan Fan; Peng Wang; Yutian Li; Karen Domenico; Qianqian Li; Xiaohong Wang; Kobina Essandoh; Jing Chen; Tianqing Peng; Guo-Chang Fan
Journal:  Mol Ther       Date:  2020-12-03       Impact factor: 11.454

8.  Distal pancreatectomy and splenectomy: a robotic or LESS approach.

Authors:  Carrie E Ryan; Sharona B Ross; Prashant B Sukharamwala; Benjamin D Sadowitz; Thomas W Wood; Alexander S Rosemurgy
Journal:  JSLS       Date:  2015 Jan-Mar       Impact factor: 2.172

Review 9.  Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive Review.

Authors:  Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2015-08-10       Impact factor: 3.747

Review 10.  Bacterial Infections Following Splenectomy for Malignant and Nonmalignant Hematologic Diseases.

Authors:  Giuseppe Leone; Eligio Pizzigallo
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-10-13       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.